InfuSystem Holdings, Inc (INFU) stock
INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 14/302% above fair value
$14.35+0.29 (+2.06%)
Close on Nov 20, 2026Market cap $285.81MP/E 35.0Yield –
InfuSystem gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
InfuSystem's gross profit for the twelve months ending Jun 30, 2026 was $82.35M, up 7.9% year over year. For fiscal 2025 it was $80.30M, up 14.1% from the year before. Over ten years it grew 4.9% a year on average. The highest annual figure on record is $80.30M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $80.30M | +14.1% |
| FY2024 | Dec 31, 2024 | $70.40M | +11.6% |
| FY2023 | Dec 31, 2023 | $63.11M | +4.2% |
| FY2022 | Dec 31, 2022 | $60.56M | +3.5% |
| FY2021 | Dec 31, 2021 | $58.54M | -0.4% |
| FY2020 | Dec 31, 2020 | $58.76M | +25.3% |
| FY2019 | Dec 31, 2019 | $46.88M | +18.5% |
| FY2018 | Dec 31, 2018 | $39.57M | -8.7% |
| FY2017 | Dec 31, 2017 | $43.36M | -3.1% |
| FY2016 | Dec 31, 2016 | $44.74M | -9.8% |
| FY2015 | Dec 31, 2015 | $49.60M | +4.7% |
| FY2014 | Dec 31, 2014 | $47.35M | +8.4% |
| FY2013 | Dec 31, 2013 | $43.68M | +1.8% |
| FY2012 | Dec 31, 2012 | $42.91M | +21.4% |
| FY2011 | Dec 31, 2011 | $35.36M | +5.4% |
| FY2010 | Dec 31, 2010 | $33.55M | +17.1% |
| FY2009 | Dec 31, 2009 | $28.64M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $21.41M | +7.7% |
| Q1 FY2026 | Mar 31, 2026 | $19.68M | +2.7% |
| Q4 FY2025 | Dec 31, 2025 | $20.44M | +12.2% |
| Q3 FY2025 | Sep 30, 2025 | $20.82M | +9.3% |
| Q2 FY2025 | Jun 30, 2025 | $19.87M | +19.2% |
| Q1 FY2025 | Mar 31, 2025 | $19.17M | +16.3% |
| Q4 FY2024 | Dec 31, 2024 | $18.22M | +9.0% |
| Q3 FY2024 | Sep 30, 2024 | $19.05M | +22.0% |
| Q2 FY2024 | Jun 30, 2024 | $16.67M | +5.3% |
| Q1 FY2024 | Mar 31, 2024 | $16.47M | +10.2% |
| Q4 FY2023 | Dec 31, 2023 | $16.71M | +18.7% |
| Q3 FY2023 | Sep 30, 2023 | $15.62M | -3.7% |
| Q2 FY2023 | Jun 30, 2023 | $15.83M | +6.2% |
| Q1 FY2023 | Mar 31, 2023 | $14.95M | -2.7% |
| Q4 FY2022 | Dec 31, 2022 | $14.07M | +3.1% |
| Q3 FY2022 | Sep 30, 2022 | $16.22M | +6.3% |
| Q2 FY2022 | Jun 30, 2022 | $14.90M | -1.0% |
| Q1 FY2022 | Mar 31, 2022 | $15.37M | +5.4% |
| Q4 FY2021 | Dec 31, 2021 | $13.65M | -9.0% |
| Q3 FY2021 | Sep 30, 2021 | $15.26M | +0.9% |
| Q2 FY2021 | Jun 30, 2021 | $15.05M | -5.8% |
| Q1 FY2021 | Mar 31, 2021 | $14.58M | +15.1% |
| Q4 FY2020 | Dec 31, 2020 | $15.00M | +15.8% |
| Q3 FY2020 | Sep 30, 2020 | $15.12M | +23.6% |
| Q2 FY2020 | Jun 30, 2020 | $15.98M | +40.7% |
| Q1 FY2020 | Mar 31, 2020 | $12.66M | +22.5% |
| Q4 FY2019 | Dec 31, 2019 | $12.95M | +29.8% |
| Q3 FY2019 | Sep 30, 2019 | $12.24M | +26.5% |
| Q2 FY2019 | Jun 30, 2019 | $11.36M | +17.2% |
| Q1 FY2019 | Mar 31, 2019 | $10.34M | +1.0% |
| Q4 FY2018 | Dec 31, 2018 | $9.97M | -12.0% |
| Q3 FY2018 | Sep 30, 2018 | $9.67M | -12.4% |
| Q2 FY2018 | Jun 30, 2018 | $9.69M | -6.3% |
| Q1 FY2018 | Mar 31, 2018 | $10.24M | -3.9% |
| Q4 FY2017 | Dec 31, 2017 | $11.33M | +6.4% |
| Q3 FY2017 | Sep 30, 2017 | $11.04M | +6.3% |
| Q2 FY2017 | Jun 30, 2017 | $10.34M | – |
| Q1 FY2017 | Mar 31, 2017 | $10.65M | – |
| Q4 FY2016 | Dec 31, 2016 | $10.65M | – |
| Q3 FY2016 | Sep 30, 2016 | $10.39M | – |
See a number that looks wrong?